[Significance of biomarkers and surrogate endpoints in preclinical and clinical trials]

Vojnosanit Pregl. 2007 Aug;64(8):561-7. doi: 10.2298/vsp0708561i.
[Article in Serbian]
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers*
  • Biomedical Research*
  • Clinical Trials as Topic*
  • Humans

Substances

  • Biomarkers